RSS   Newsletter   Contact   Advertise with us
Post Online Media

Oragenics names Alan Joslyn president and CEO

OragenicsOragenics, a developer of novel antibiotics, announced that Alan Joslyn was named president and chief executive officer, and as a member the company’s board of directors.

Most recently, Dr. Joslyn was a partner in Lazarus Pharmaceuticals.

Prior to that he served as the Chief Executive Officer and Director of several privately held companies including Edusa Pharmaceuticals and Sentinella Pharmaceuticals and prior to that he was the Senior Vice-President Research and Development of Penwest Pharmaceuticals and also held senior drug development positions with Johnson & Johnson.


 LATEST MOVES FROM Florida 





More inside POST
 
 

We use cookies to ensure that we give you the best experience on our website. Please allow cookies for fully-functioning website.

Allow Cookies Privacy Policy